Display options
Cite
Cugini P, Lucia P, Scibilia G, et al. Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants. Br Heart J. 1993;70(4):363-5doi: 10.1136/hrt.70.4.363.
Cugini, P., Lucia, P., Scibilia, G., Di Palma, L., Cioli, A. R., Cianetti, A., Gasbarrone, L., Canova, R., & Marino, B. (1993). Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants. British heart journal, 70(4), 363-5. https://doi.org/10.1136/hrt.70.4.363
Cugini, P, et al. "Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants." British heart journal vol. 70,4 (1993): 363-5. doi: https://doi.org/10.1136/hrt.70.4.363
Cugini P, Lucia P, Scibilia G, Di Palma L, Cioli AR, Cianetti A, Gasbarrone L, Canova R, Marino B. Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants. Br Heart J. 1993 Oct;70(4):363-5. doi: 10.1136/hrt.70.4.363. PMID: 8217446; PMCID: PMC1025333.
Copy Download .nbib Format: NLM
Share it on
Full text links
HighWire Free PMC Article

Br Heart J. 1993 Oct;70(4):363-5. doi: 10.1136/hrt.70.4.363.

Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants.

British heart journal

P Cugini, P Lucia, G Scibilia, L Di Palma, A R Cioli, A Cianetti, L Gasbarrone, R Canova, B Marino

Affiliations

  1. Institute of Heart and Large Vessels Surgery, University La Sapienza, Rome, Italy.

PMID: 8217446 PMCID: PMC1025333 DOI: 10.1136/hrt.70.4.363
Free PMC Article

Abstract

OBJECTIVE: To study the circadian pattern of plasma concentrations of vasoactive intestinal peptide (VIP) in patients with orthotopic heart transplants. Circulating VIP is known to have neural and immunological sources.

PATIENTS AND METHODS: 13 patients with orthotopic heart transplants were studied 12-53 months (mean 31.8 months) after operation. All were haemodynamically compensated and had no histological evidence of rejection. They were being treated with cyclosporin, azathioprine, and prednisone. Ten healthy individuals were studied as controls. Circulating VIP was assayed six times within a 24h period. Time qualified data were analysed by ANOVA and the cosinor method. Student's t test for unpaired data and Bingham's test for cosinor-derived parameters were used for statistical comparisons.

RESULTS: Plasma concentrations of VIP were lower in the patients with orthotopic heart transplants than in the controls (p < 0.001). ANOVA and the cosinor method respectively showed a statistically significant within-day variability and circadian rhythm in the controls but not in the patients with heart transplants.

DISCUSSION: The low plasma concentrations of VIP in the patients with heart transplants could be the result of the lack of contribution by the cardiac VIPergic fibres, a reduction of VIP release by the pharmacologically suppressed immune system, the inhibitory effects of cyclosporin on neural function and humoral secretions, and the effects of negative feedback on VIP release of high concentrations of atrial natriuretic peptide. The lack of the circadian rhythm suggests a structural disorder, which should be further investigated.

References

  1. Gen Pharmacol. 1987;18(6):577-87 - PubMed
  2. Regul Pept. 1991 Jul 9;34(3):141-8 - PubMed
  3. Postgrad Med J. 1979 Feb;55(640):105-16 - PubMed
  4. Digestion. 1979;19(3):149-69 - PubMed
  5. Neuroscience. 1979;4(11):1539-59 - PubMed
  6. J Lab Clin Med. 1980 Oct;96(4):666-72 - PubMed
  7. Gastroenterology. 1980 Dec;79(6):1288-94 - PubMed
  8. Am J Gastroenterol. 1981 Oct;76(4):338-41 - PubMed
  9. Mol Cell Endocrinol. 1982 Aug;27(3):243-62 - PubMed
  10. Lancet. 1982 Dec 4;2(8310):1274 - PubMed
  11. Lancet. 1983 Mar 5;1(8323):539 - PubMed
  12. Chronobiologia. 1982 Oct-Dec;9(4):397-439 - PubMed
  13. Br Med J (Clin Res Ed). 1984 Jan 7;288(6410):9-11 - PubMed
  14. Brain Res. 1984 Feb 6;292(2):269-82 - PubMed
  15. Clin Exp Hypertens A. 1984;6(1-2):91-106 - PubMed
  16. Neurosci Lett. 1983 Dec 30;43(2-3):263-9 - PubMed
  17. Scand J Clin Lab Invest. 1984 Jun;44(4):347-51 - PubMed
  18. Cell Tissue Res. 1984;236(3):527-40 - PubMed
  19. Peptides. 1984 Mar-Apr;5(2):341-53 - PubMed
  20. Clin Exp Hypertens A. 1984;6(10-11):1867-71 - PubMed
  21. J Lab Clin Med. 1985 Nov;106(5):542-50 - PubMed
  22. J Immunol. 1986 Jan;136(1):152-6 - PubMed
  23. Kidney Int. 1985 Nov;28(5):767-74 - PubMed
  24. J Auton Nerv Syst. 1986 Sep;17(1):21-32 - PubMed
  25. Am J Kidney Dis. 1986 Nov;8(5):323-31 - PubMed
  26. Br Med J (Clin Res Ed). 1986 Nov 29;293(6559):1391-2 - PubMed
  27. Clin Sci (Lond). 1987 Feb;72(2):195-200 - PubMed
  28. Am J Cardiol. 1987 Dec 1;60(16):1356-61 - PubMed
  29. Kidney Int. 1988 Feb;33(2):590-600 - PubMed
  30. Transplant Proc. 1988 Jun;20(3 Suppl 3):969-78 - PubMed
  31. Transplantation. 1988 Oct;46(4):601-2 - PubMed
  32. Endocrinology. 1989 Oct;125(4):1983-90 - PubMed
  33. Am J Physiol. 1989 Oct;257(4 Pt 2):H1082-7 - PubMed
  34. N Engl J Med. 1990 Feb 1;322(5):336 - PubMed
  35. Am J Cardiol. 1992 Feb 1;69(4):397-402 - PubMed
  36. Circ Res. 1990 Apr;66(4):900-12 - PubMed
  37. Eur J Clin Invest. 1990 Apr;20(2):192-8 - PubMed
  38. N Engl J Med. 1990 Sep 13;323(11):693-9 - PubMed
  39. Circ Res. 1990 Oct;67(4):986-92 - PubMed
  40. Circ Res. 1990 Dec;67(6):1323-33 - PubMed
  41. Lancet. 1976 May 8;1(7967):991-3 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources